About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
EP Lab Digest Panel Q&A
By
CVRx | Barostim
FEATURING
Joann Lindenfeld
,
Robert Canby
,
Nirav Raval
,
Bradley Knight
By
CVRx | Barostim
FEATURING
Joann Lindenfeld
,
Robert Canby
,
Nirav Raval
,
Bradley Knight
132 views
April 1, 2021
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:08
CVRx | Barostim
Integrating Barostim into a Comprehensive Heart Failure Program ISHL…
Feat.
D. Yaranov,
P. Patel,
R. Gupta,
J. Schmitto,
E. Chung
16:36
CVRx | Barostim
Beyond BeAT-HF - Real World Experience with Barostim
Feat.
P. Patel
11:08
CVRx | Barostim
Integrating Barostim into a Comprehensive Heart Failure Program
Feat.
R. Gupta
16:18
CVRx | Barostim
ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure …
Feat.
D. Yaranov
10:21
CVRx | Barostim
Patient Identification and Post-Implant Management within an Advance…
Feat.
D. Yaranov
17:33
CVRx | Barostim
Beyond BeAT-HF: Real World Experience with Barostim
Feat.
G. Panjrath
15:57
CVRx | Barostim
Long-Term Results of the BeAT-HF Clinical Study
Feat.
J. Lindenfeld
13:58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
Feat.
J. Thomas Heywood
11:18
CVRx | Barostim
Barostim and the Window of Opportunity in Class II/III HFrEF Patient…
Feat.
G. Panjrath,
D. Yaranov,
J. Lindenfeld,
J. Thomas Heywood
18:36
CVRx | Barostim
Barostim and the Window of Opportunity in Class II/III HFrEF Patient…
Feat.
W. Abraham,
G. Panjrath,
D. Yaranov,
P. Mccann
09:58
CVRx | Barostim
Barostim for HFrEF Patients
Feat.
P. Mccann
10:18
CVRx | Barostim
New Insights from the BeAT-HF Clinical Study
Feat.
W. Abraham
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
12:16
CVRx | Barostim
HFSA 2023: Window of Opportunity – Who and When
Feat.
G. Panjrath
16:32
CVRx | Barostim
ESC 2023: BeAT-HF: Long term outcome
Feat.
M. Zile
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
11:43
CVRx | Barostim
ESC 2023: Real-world experience with Baroreflex Activation Therapy
Feat.
F. Arribas
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
16:00
CVRx | Barostim
HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes
Feat.
F. Zannad
12:14
CVRx | Barostim
HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF
Feat.
J. Lindenfeld